Emerging drugs for autonomic dysfunction in Parkinson's disease
Open Access
- 1 February 2013
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Emerging Drugs
- Vol. 18 (1) , 39-53
Abstract
(2013). Emerging drugs for autonomic dysfunction in Parkinson's disease. Expert Opinion on Emerging Drugs: Vol. 18, No. 1, pp. 39-53.Keywords
This publication has 92 references indexed in Scilit:
- Effects of breathing frequency on baroreflex effectiveness index and spontaneous baroreflex sensitivity derived by sequence analysisJournal Of Hypertension, 2012
- Factors related to orthostatic hypotension in Parkinson's diseaseParkinsonism & Related Disorders, 2012
- Immediate effect of chandra nadi pranayama (left unilateral forced nostril breathing) on cardiovascular parameters in hypertensive patientsInternational Journal of Yoga, 2012
- Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?Movement Disorders, 2011
- Orexin A in rat rostral ventrolateral medulla is pressor, sympatho‐excitatory, increases barosensitivity and attenuates the somato‐sympathetic reflexBritish Journal of Pharmacology, 2011
- Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysisGut, 2011
- Management of neurogenic orthostatic hypotension: an updateThe Lancet Neurology, 2008
- Sialorrhoea and Drooling in Patients with Parkinson’s DiseaseDrugs & Aging, 2008
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030Neurology, 2007
- Benefit-Risk Assessment of Tolterodine in the Treatment of Overactive Bladder in AdultsDrug Safety, 2004